Display Settings:

Format

Send to:

Choose Destination

    J Biol Chem. 1994 Jul 15;269(28):18572-5.

    Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion.

    Chang XB, Hou YX, Jensen TJ, Riordan JR.

    Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

    Technical difficulties in obtaining three-dimensional structures of intrinsic membrane proteins continues to limit understanding of their function. However, considerable insight can be gained from their two-dimensional topological arrangement in the lipid bilayer. Efficient molecular genetic approaches are available to discern the topology of prokaryotic but not of eukaryotic membrane proteins. The absolute asymmetry of the sidedness of their N-glycosylation was employed here to develop such a method using the cystic fibrosis transmembrane conductance regulator (CFTR). Insertion by in vitro mutagenesis of N-glycosylation consensus sequences (NXS/T) in predicted cytoplasmic and extracytoplasmic loops between hydrophobic sequences capable of traversing the membrane established the membrane topology of CFTR. This provides the first experimental evaluation of the original topological model of CFTR based solely on hydropathy algorithms and a method which may be generally applicable for the in vivo evaluation of the topology of other mammalian membrane proteins.

    PMID: 7518437 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Theophylline (Bronkodyl®, Elixophyllin®, Slo-bid®, ...)

      Theophylline is used to prevent and treat wheezing, shortness of breath, and difficulty breathing caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, ...